Cover Image
市場調查報告書

血管炎:全球臨床實驗檢討

Vasculitis Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 235294
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
血管炎:全球臨床實驗檢討 Vasculitis Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月28日 內容資訊: 英文 81 Pages
簡介

本報告提供血管炎相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7·E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,並彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 血管炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:血管炎臨床實驗數量上心臟血管臨床實驗數量所佔比例

Phase別臨床實驗數量:G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:血管炎臨床實驗數量上心臟血管臨床實驗數量所佔比例

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗的主要參與企業 - 血管炎治療藥

有潛力的藥劑

  • 最新臨床實驗新聞: 血管炎

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • Zenyaku Kogyo Co., Ltd.
    • Pluristem Therapeutics Inc.
    • GlaxoSmithKline plc
    • ChemoCentryx, Inc.
    • AnGes MG, Inc.
    • Actelion Ltd
    • AbbVie Inc.
  • 有代表性的研究機關/醫院臨床實驗概要
    • Assistance Publique - Hopitaux de Paris
    • The National Institute of Allergy and Infectious Diseases
    • Cambridge University Hospitals NHS Foundation Trust
    • 琦玉醫科大學
    • Ministry of Health, Labour and Welfare, Japan
    • Nanjing University
    • 大阪大學
    • Pitie-Salpetriere Hospital
    • University Hospital, Toulouse
    • University Medical Center Groningen

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2668CTIDB

GlobalData's clinical trial report, "Vasculitis Global Clinical Trials Review, H1, 2015" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Vasculitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Vasculitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Vasculitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Vasculitis
    • Apr 21, 2015: Kineta, University of Groningen Present New, Positive Data for Dalazatide in ANCA Vasculitis, an Orphan Disease
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Zenyaku Kogyo Co., Ltd.
      • Clinical Trial Overview of Zenyaku Kogyo Co., Ltd.
      • Pluristem Therapeutics Inc.
      • Clinical Trial Overview of Pluristem Therapeutics Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • ChemoCentryx, Inc.
      • Clinical Trial Overview of ChemoCentryx, Inc.
      • AnGes MG, Inc.
      • Clinical Trial Overview of AnGes MG, Inc.
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Cambridge University Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Ministry of Health, Labour and Welfare, Japan
      • Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan
      • Nanjing University
      • Clinical Trial Overview of Nanjing University
      • Osaka University
      • Clinical Trial Overview of Osaka University
      • Pitie-Salpetriere Hospital
      • Clinical Trial Overview of Pitie-Salpetriere Hospital
      • University Hospital, Toulouse
      • Clinical Trial Overview of University Hospital, Toulouse
      • University Medical Center Groningen
      • Clinical Trial Overview of University Medical Center Groningen
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Vasculitis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Vasculitis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Vasculitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Vasculitis to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Vasculitis to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Vasculitis Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Vasculitis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Vasculitis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zenyaku Kogyo Co., Ltd., 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pitie-Salpetriere Hospital, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2015*
  • Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015*

List of Figures

  • Vasculitis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Vasculitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Vasculitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Vasculitis to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Vasculitis to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top